Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YZJ-4729 for Postoperative Pain After Abdominal Surgery
NCT06890533Phase 3Active, not recruiting
- Sponsor
- Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
- Start
- May 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of YZJ-4729 in acute postoperative pain, sponsored by Shanghai Haiyan Pharmaceutical Technology Co., Ltd.. Started May 2025; status: active, not recruiting.
02
Drugs
YZJ-4729
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on NCT06890533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06890533.